Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Brain atrophy at onset and physical disability in multiple sclerosis.
Repeatability of the timed 25-foot walk test for individuals with multiple sclerosis.
Targeting erythropoietin for chronic neurodegenerative diseases.
Use of a Standardized MxA Protein Measurement-Based Assay for Validation of Assays for the Assessment of Neutralizing Antibodies Against Interferon-β
Clarification on neuromuscular conditions in careers article.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Using Twitter to investigate opinions about multiple sclerosis treatments: a descriptive, exploratory study.
Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis.
Delayed initial recovery and long lie following a fall among middle-aged and older adults with multiple sclerosis.
Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".
Functional brain networks: Linking thalamic atrophy to clinical disability in multiple sclerosis, a multimodal fMRI and MEG Study.
[Contrast agents in MRI-diagnosis of multiple sclerosis].
Treadmill Training or Progressive Strength Training to Improve Walking in People with Multiple Sclerosis? A Randomized Parallel Group Trial.
Association between alcohol consumption and multiple sclerosis: a meta-analysis of observational studies.
Factors influencing long-term outcomes in relapsing-remitting multiple sclerosis: PRISMS-15.
Interest in providing multiple sclerosis care and subspecializing in multiple sclerosis among neurology residents.
Multiple sclerosis registries in Europe - results of a systematic survey.
Disentangling Multiple Sclerosis and depression: an adjusted depression screening score for patient-centered care.
Macrophages derived from infiltrating monocytes mediate autoimmune myelin destruction.
Cerebrospinal fluid myelin basic protein is frequently ordered but has little value: a test utilization study.
Erratum to: Promoting Remyelination in Multiple Sclerosis-Recent Advances.
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
Vitamin D supplementation in multiple sclerosis patients in 2012: hype or reality as an adjunctive therapy?
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Pages
« first
‹ previous
…
336
337
338
339
340
341
342
343
344
…
next ›
last »